Gainers

• Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday's pre-market session. The company's market cap stands at $2.5 million.
• Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 29.19% to $1.64. The company's market cap stands at $8.1 million.
• NextCure (NASDAQ:NXTC) shares moved upwards by 16.29% to $2.07. The market value of their outstanding shares is at $6.4 million.
• Nexalin Technology (NASDAQ:NXL) shares rose 10.22% to $0.4. The market value of their outstanding shares is at $7.8 million.
• Satellos Bioscience (NASDAQ:MSLE) shares increased by 9.87% to $9.02. The market value of their outstanding shares is at $171.0 million.
• Verrica Pharmaceuticals (NASDAQ:VRCA) stock rose 8.73% to $6.6. The market value of their outstanding shares is at $104.2 million.

Losers

• BiomX (AMEX:PHGE) stock decreased by 15.7% to $0.25 during Wednesday's pre-market session. The company's market cap stands at $3.5 million.
• Bone Biologics (NASDAQ:BBLG) stock declined by 12.93% to $1.28. The market value of their outstanding shares is at $2.6 million.
• BioLine Rx (NASDAQ:BLRX) shares fell 11.31% to $2.8. The market value of their outstanding shares is at $13.7 million.
• Tenon Medical (NASDAQ:TNON) stock declined by 10.87% to $0.22. The company's market cap stands at $4.2 million.
• Chemomab Therapeutics (NASDAQ:CMMB) shares fell 10.85% to $2.47. The market value of their outstanding shares is at $19.9 million.
• Liminatus Pharma (NASDAQ:LIMN) shares fell 9.5% to $0.12. The market value of their outstanding shares is at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.